Enable JavaScript to visit this website.

Foundations of Science

Inside a Cytokine Storm: When Your Immune System is Too Strong

Inside a Cytokine Storm: When Your Immune System is Too Strong

Inside a Cytokine Storm: When Your Immune...

The vast majority of people who suffer severe complications from influenza are elderly or have compromised immune systems. In fact, almost 90% of people who die as a result of a flu infection in the United States are over 65, an age when the immune system’s ability to fight infection begins to...

How to Deal Dangerous Proteins a Knockout Blow

How to Deal Dangerous Proteins a Knockout Blow

How to Deal Dangerous Proteins a Knockout Blow

In the genteel game of croquet, the goal is deceptively straightforward: to hit your ball through a series of hoops before your opponent does. However, anyone who has picked up a mallet knows the sport can get downright cutthroat. A strong player with the right strategy can hit her opponent’s...

May the Best Cell Win: How Scientists Choose One Champion Out of Millions

May the Best Cell Win: How Scientists Choose One Champion Out of Millions

May the Best Cell Win: How Scientists Choose...

Making cells in the lab may not sound too dramatic, but under the microscope, what scientists call cell-line development can be even more competitive than the most cutthroat reality-show contests.  ...

Inside the X-(Chromosome) Files

Inside the X-(Chromosome) Files

Inside the X-(Chromosome) Files

In honor of Mother’s Day, let’s take a closer look at the “female” sex chromosome: The X.  ...

Treating Disease with 'Precision Medicines' that Target Specific Patients

Treating Disease with 'Precision Medicines' that Target Specific Patients

Treating Disease with 'Precision Medicines'...

When people talk about curing cancer, an oncologist’s reaction likely is: What kind of cancer? If you answer “breast cancer,”  the oncologist will likely want to know which of its many varieties do you mean?  ...

 Could Diversity in Clinical Trials Be the Key to Understanding Liver Disease? 

Could Diversity in Clinical Trials Be the Key to Understanding Liver Disease? 

Could Diversity in Clinical Trials Be the Key...

In a New Yorker article about how evolutionary psychology findings are usually based on surveys of undergraduates, Anthony Gottlieb wrote, “American college kids, whatever their charms, are a laughable proxy for Homo sapiens.”  ...

There’s No ‘I’ in Drug Development

There’s No ‘I’ in Drug Development

There’s No ‘I’ in Drug Development

Scientific collaborations between researchers, organizations and universities can help yield better results for patients.  ...

How the Placebo Effect Can Cloud Clinical Trial Results

How the Placebo Effect Can Cloud Clinical Trial Results

How the Placebo Effect Can Cloud Clinical Trial...

When researchers design a clinical trial, they can’t ignore the powerful—and often bizarre—placebo effect. ...

Hope in the Cancer Battle: Declining Cancer Rates, Innovative Science Breakthroughs

Hope in the Cancer Battle: Declining Cancer Rates, Innovative Science Breakthroughs

Hope in the Cancer Battle: Declining Cancer...

The rate of deaths from all cancers combined continued its quarter-century-long steady decline in the U.S., according to the latest report by the American Cancer Society, with the death rate dropping 1.7 percent between 2014 and 2015— the latest year for which national statistics were available....

Get the Latest Updates